Lin YC - Search Results

1

Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy.

Su PH, Hsu CC, Hsueh SW, Hung CY, Yeh KY, Wang HM, Lu CH, Lin YC, Chang JT, Chou WC. Su PH, et al. Among authors: lin yc. Anticancer Res. 2022 Nov;42(11):5609-5618. doi: 10.21873/anticanres.16069. Anticancer Res. 2022. PMID: 36288852

2

A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening.

Lung J, Hung MS, Lin YC, Jiang YY, Fang YH, Lu MS, Hsieh CC, Wang CS, Kuan FC, Lu CH, Chen PT, Lin CM, Chou YL, Lin CK, Yang TM, Chen FF, Lin PY, Hsieh MJ, Tsai YH. Lung J, et al. Among authors: lin ck, lin yc, lin cm, lin py. Sci Rep. 2020 Oct 9;10(1):16943. doi: 10.1038/s41598-020-72809-7. Sci Rep. 2020. PMID: 33037234 Free PMC article.

3

A comparison of the MNA-SF, MUST, and NRS-2002 nutritional tools in predicting treatment incompletion of concurrent chemoradiotherapy in patients with head and neck cancer.

Hsueh SW, Lai CC, Hung CY, Lin YC, Lu CH, Yeh KY, Tsang NM, Hung YS, Chang PH, Chou WC. Hsueh SW, et al. Among authors: lin yc. Support Care Cancer. 2021 Sep;29(9):5455-5462. doi: 10.1007/s00520-021-06140-w. Epub 2021 Mar 11. Support Care Cancer. 2021. PMID: 33704566

4

Author Correction: A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening.

Lung J, Hung MS, Lin YC, Jiang YY, Fang YH, Lu MS, Hsieh CC, Wang CS, Kuan FC, Lu CH, Chen PT, Lin CM, Chou YL, Lin CK, Yang TM, Chen FF, Lin PY, Hsieh MJ, Tsai YH. Lung J, et al. Among authors: lin ck, lin yc, lin cm, lin py. Sci Rep. 2021 Jun 15;11(1):12952. doi: 10.1038/s41598-021-92318-5. Sci Rep. 2021. PMID: 34131256 Free PMC article. No abstract available.

5

Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy.

Huang YH, Hung YS, Lai CC, Ho MM, Yeh KY, Yang C, Lu CH, Tseng CK, Tsang NM, Hung CY, Hsueh SW, Chang PH, Ho YW, Lin YC, Chou WC. Huang YH, et al. Among authors: lin yc. Anticancer Res. 2021 Oct;41(10):5213-5222. doi: 10.21873/anticanres.15340. Anticancer Res. 2021. PMID: 34593474

6

Paclitaxel and Carboplatin Versus Cisplatin and 5-Fluorouracil in Concurrent Chemoradiotherapy in Patients With Esophageal Cancer.

Su PH, Hsueh SW, Tseng CK, Ho MM, Su PJ, Hung CY, Yeh KY, Chang PH, Hung YS, Ho YW, Lin YC, Chou WC. Su PH, et al. Among authors: lin yc. In Vivo. 2021 Nov-Dec;35(6):3391-3399. doi: 10.21873/invivo.12638. In Vivo. 2021. PMID: 34697174 Free PMC article.

7

A Muscle Biosignature Differentiating Between Limb-Girdle Muscular Dystrophy and Idiopathic Inflammatory Myopathy on Magnetic Resonance Imaging.

Hsu WC, Lin YC, Chuang HH, Yeh KY, Chan WP, Ro LS. Hsu WC, et al. Among authors: lin yc. Front Neurol. 2021 Dec 20;12:783095. doi: 10.3389/fneur.2021.783095. eCollection 2021. Front Neurol. 2021. PMID: 34987467 Free PMC article.

8

Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.

Chou WC, Lai CC, Hung CY, Hsueh SW, Yeh KY, Lu CH, Tsang NM, Chang PH, Ho YW, Chen SY, Lin YC, Hung YS. Chou WC, et al. Among authors: lin yc. Cancer Control. 2022 Jan-Dec;29:10732748211045276. doi: 10.1177/10732748211045276. Cancer Control. 2022. PMID: 34994207 Free PMC article.

9

Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy.

Lin YC, Wang CH, Ling HH, Pan YP, Chang PH, Chou WC, Chen FP, Yeh KY. Lin YC, et al. Biomedicines. 2022 Feb 6;10(2):388. doi: 10.3390/biomedicines10020388. Biomedicines. 2022. PMID: 35203597 Free PMC article.

10

Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision.

Wang CH, Ling HH, Liu MH, Pan YP, Chang PH, Lin YC, Chou WC, Peng CL, Yeh KY. Wang CH, et al. Among authors: lin yc. Cancers (Basel). 2022 Jun 24;14(13):3112. doi: 10.3390/cancers14133112. Cancers (Basel). 2022. PMID: 35804884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,280 results

Search Page